Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Clinical trial NCT07190222 · RECRUITING
Trial details
- NCT number
- NCT07190222
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-17
- Primary completion
- 2029-11-27
- Enrollment
- 942
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.